chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 24 hours of receiving vaccines patient spiked fever to 40.5 which did not respond to tylenol or motrin.  She was admitted to hospital to rule out sepsis and for dehydration  on 11/2 and is currently still in the hospital.  All cultures have been negative except for stool culture positive for E coli and Rotavirus (which she is vaccinated for).  She is still having signifcant diarrhea. She has no siblings, does not attend daycare and no sick contacts at home.
Patient received her 1st covid vaccination. She wanted to walk around and shop during her 15 minute post-vaccine monitoring period. She stated she was dizzy and notified her father, who was able to get her to the ground safely. I (the pharmacist) was notified; when I approached her she was sitting up with a cold bottle of water. I verified it was not an anaphylaxis reaction, then offered a seat and ice packs to cool down. She stated she was dizzy and nauseous. dad sais she was anxious about the vaccine. After sitting for 15 minutes, supervised by the pharmacist, she said she felt better. She was bale to stand and walk out of the pharmacy.
Eyes itching; Light sensitivity; Eyes water; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 16Apr2021 at 15:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient is allergic to bees and has been admitted in the hospital multiple times because of bee stings which caused throat swelling and eyes itch. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Apr2021 at 16:15 after about 30 minutes from getting the first dose of the vaccine, the patient eyes started itching, eyes water and had light sensitivity. It immediately took him back to being a 12-year-old and being stung by a bee. He had been sitting in the dark for about 20 minutes. It had been over 30 years since he had this feeling. He did not know if he was just weird but he thought he should pass the message along. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes started itching, light sensitivity and eyes water was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Immediately after administration of MMR-patient developed rash and hive at and surrounding injection site. Topical cortisone and oral BENADRYL.
Case number PHEH2013US008149 is an initial spontaneous report received from a physician on 08 Apr 2013. This report refers to a patient whose identifiers were not reported. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported, hence conservatively coded as MENVEO INN) on an unknown date. On an unspecified date, the patient developed encephalitis. The outcome of the event was not reported. The physician reported that the causality of encephalitis was temporally associated to meningitis vaccination.
This spontaneous report as received from a pharmacist via company representative refers to a 70 year old female patient. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date, dose were not reported) subcutaneous. No concomitant medications were reported. On an unkonwn date the patient experienced redness at injection site. The patient sought medical attention, she went to see the pharmacist. The outcome of redness at injection site was reported as recovered on an unknown date. The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Initial report received from a health care professional on 17 October 2007. A 60-year-old female with a history of asthma and allergies to Biaxin and Keflex had received a left deltoid intramuscular injection of Fluzone (lot number U2463AA). On 16 October 2007 and immediately after vaccination, she experienced paresthesia in her left cheek and lip. The patient also experienced soreness at the injection site on the left deltoid on an unspecified date. The patient had received three previous doses of Fluzone. At the time of the report, the patient had not recovered. No additional information was provided. The reporter of this case is the same as for case 2007-03521, which involves a nodule at test site of left forearm following receipt of Tubersol, lot number C2461AA.
No adverse event; Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 10-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of Bivalent vaccine).    No concomitant product use was reported.  On 14-Oct-2022, a dosing error occurred with a couple of patients. Doses of Blue capped purple-bordered (Ages 6-11 MONOVALENT) given instead of Blue capped gray-bordered (Ages 6 and older BIVALENT) booster doses.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-659880 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-659880:Master Case
This spontaneous report was received from a female patient of unknown age. The patient's historical condition included a bacterial infection in the lungs, experienced in approximately 2013 (reported as about 5 years ago), severe enough to cause scarring to occur in the lungs. It was reported that as a result of the scarring in the patient's lungs, she became more prone to getting bacterial pneumonia. On an unknown date in approximately 2014 (reported as about 4 years ago), the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, site and route of administration, lot # and expiration date were not provided) for prophylaxis. In January 2018, the patient developed a bacterial pneumonia infection. In June 2018, she experienced another bacterial related pneumonia infection. On an unknown date, she developed an unspecified allergies, which were reported as bad. On unknown dates (reported as sometimes), because of her bad allergies, the patient was experiencing nasal drips and coughing up blood. The patient sought medical attention via contacting her infectious disease physician. The outcome of the events was unknown. The relatedness between the events and PNEUMOVAX 23 was not reported. Upon internal review, the event of bacterial pneumonia infection was considered to be medically significant.
vomiting, fever freq of stools in 24 hs sxs subsided p/3 days;
Showed signs of 1st symptoms 8 days after I received the 1st Pfizer Vaccine shot.  Was diagnosed w Aggregatibacter (HAEMOPHILUS) Aphrophilus - Salivary Gland Infection
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Pt received IM pfizer 1520 vaccine onset of slight itching to throat without noted swelling 1550 pt turned around in car drove back to cvs received 25 mg benadryl po at 1602 pt monitored in observation area back and neck blotching with goose bumps noted. pt speech remained clear speaking full sentences. Pt blotching to neck and anterior neck improved pt itching improved with second dose of benadryl given at 1620. Pt parents arrived has epipen at home sent with benadryl education done. pcp to cal
Extreme pain left arm extending up to neck, palpable lymph node, left supra clavicular, seen 9/7/12, refused medical attention. Seen by PCP 9/10/12 labs ordered, pending at present time.
enlargement of the spinal cord; tachycardia; paresthesia; burning feeling in the head/face; This is a spontaneous report from a non-contactable consumer. This reporter reported two reports. This is one of the two reports. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation.  The patient medical history was not reported. There were no concomitant medications. It was reported that, at the time of the call the reporter mentioned to the agent that he met with a patient who experienced the same events after the vaccination, which was tachycardia, paraesthesia, burning feeling in the head/face. The reporter mentioned that the patient was feeling better. After a spinal cord test [reporter did not remember which one] it was found that the patient symptoms were caused by an enlargement of the spinal cord. The outcome was unknown for the reported event.  The events occurred in a country different from that of the reporter. This may be a duplicate report if another reporter from the country where the event occurred has submitted the same information to his/her local agency.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101506751 same reporter/AE/SD, different patient
Loose bowels to diarrheas; shoulder pain in joint, right arm; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL 9266) via an unspecified route of administration in his right arm on 19Feb2021 at 11:00 AM as single dose for COVID-19 immunisation. The patients medical history includes that of previous tonsillar cancer treated and clear. Patient was allergic to cipro and tomatoes. He previously received first dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient had received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID-19 prior to vaccination. He had not tested positive for COVID-19 since the vaccine. On 20Feb2021 at 09:00 AM, the patient experienced loose bowels to diarrhea, shoulder pain in joint, right arm, fatigue and brain fog. Patient did not receive any treatment for events. The clinical outcome of all events was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a healthcare business professional who was an office manager referring to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided. On an unknown date, the reporter stated that it was unable to confirm if patient was previously administered with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for prophylaxis (circumstance or information capable of leading to medication error). On 03-JAN-2022, the patient had missed a scheduled measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and another missing on 07-JAN-2022 (product dose omission issue). No additional AE reported. No PQC.
prolonged itchy rash/reaction / itchy rash; allergic reaction; rash is little dots on her entire body; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced itchy rash, allergic reaction and blotchy rash. On an unknown date, the outcome of the itchy rash and blotchy rash were not recovered/not resolved and the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the itchy rash, allergic reaction and blotchy rash to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient herself.  The patient received the 1st Shingrix shot and was experiencing a prolonged itchy rash/reaction.  She was calling to see if anyone in clinical trials reported a prolonged itchy rash and to see if she should get the 2nd Shingrix dose or not. The patient said the itchiness was more bothersome than the rash.  The rash was little dots on her entire body.  The rash started initially on her stomach. The patient had gone to the doctor (including a dermatologist) on 3 occasions regarding this issue but they had not been able to definitively give her an answer as to what was causing the itchy rash.  The patient thought might be she had shingles but the doctor said no.  The doctor thought that she had a fungal infection but later she was told that was not the case.  The next step was for her to get allergy testing to confirm if it was an allergic reaction. The reporter said she did not know the exact onset date but it had been an ongoing issue since after the shot.  The reporter consented to follow up.
Starting about 2 weeks after vaccine administration in left deltoid, patient started having a blotchy rash on left inner forearm. It looks like a giant bruise or almost like bleeding under the skin. Dark round circles.   No pain, swelling, itchiness, or fluid. No pain on applying pressure to it. Was worried it was a blood clot but we think it is associated with receiving the vaccine as it is only in the left forearm. Patient states that it is "clearing up".
DEATHLY ILL; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced deathly ill. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of deathly ill was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not needed as per standard procedure since case is assessed as non-serious.
per patients mother: pt had complained of dizzyness right after leaving clininc. Mother was driving, she said that about 5 minutes later pt started getting hot flashes and had developed a rash across chest, decided to drive to hospital on the way there she progressively got worse she started to complaine of chest tightness/pain. once at ER she double over from severe stomach pain-said it felt like she had to go to the bathroom. Mom said that things quickly worsened. She started to have throat swelling. Epinepherine was administered and IV benedryl, pt stayed in ER and was observed for several hours. Mom reports they were sent home around 4pm and around 7320pm that night pt started feeling tightness in her chest and difficulty breathing mom gave epinephirine and called 911. EMT's transported her back to ER. She was stablized and sent home. pt continued to have these episodes of Chest tightening and difficulty breathing resulting in several more visits to the ER and one over night stay. Last visit to the Hopsital was on 4/15/21
3/5 pm had IZ's. 3/6 430pm (R) arm started itching no swelling up - mom put ice pk. APAP & rubbed calamine lotion. Mom to continue ice & give BENADRYL x 5 days today 3/7 on exam upper (R) arm 7" x 6" firm pink warm patch (R) arm and (L) arm circ 8".
tinnitus crunching and whooshing sounds in ears.; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus crunching and whooshing sounds in ears.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus crunching and whooshing sounds in ears.). At the time of the report, TINNITUS (tinnitus crunching and whooshing sounds in ears.) outcome was unknown.            No concomitant medication were provided. No treatment details were provided.
Arm is more sore than usual with flu shot. Her arm is still sore even though she got the shot one month ago. It was very sore at first, but it is now only sore to the touch so she is improving.
This spontaneous report as received from a patient via Market Research refers to himself or herself. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route not reported0. The patient felt on 26-OCT-2013 injuring by left shoulder and arm. The patient went to the doctor and at that time did not have a rash on the patient's arm, just pain in the shoulder joint and upper arm area. The patient was given pain medications and told that the patient had pulled muscles. On 31-OCT-2013 ("five days later"), the patient developed a red rash, then fluid filled pus pockets beginning at my shoulder going down to the hand and into fingers. The patient went to doctor on 02-NOV-2013 ("Sunday") and was told that it was contact dermatitis and if it was the shingles it was to late to begin viral medications. The patient was given prednisone shot and pills to take. On 05-NOV-2013 morning ("Tuesday morning") the patient woke up with severe shoulder joint pain, more blisters, and swollen arm, the patient went to the regular doctor was told the patient had full blown shingles and the doctor wanted the patient to stop the prednisone and wrote prescription for a viral medication to begin taking immediately and stronger pain medications. The patient was at home resting and felt terrible. The doctor was hoping that the viral medications will help. The outcome of the events was unknown. Additional information has been requested.
Initial report received from a physician on 20 May 2011. A 17-year-old female patient had received an intramuscular right deltoid injection of MENACTRA (lot number U3556AA) on 19 May 2011 and the next morning she called the physician's office to report she had a fever, headache, nausea, and right arm and neck pain. She was being evaluated that day in the office. It was unknown if the patient had received any other vaccinations with 4 weeks prior to 19 May 2011. No relevant diagnostic tests and/or laboratory data were completed as of 20 May 2011. The patient had no concurrent illnesses or pre-existing medical conditions at time of vaccination. She was however taking birth control medication (not identified). The patient had not experienced any adverse events with prior vaccinations. At the time of this report, the patient had not recovered. Documents held by sender: None.
pt recv vax 16JAN97 & 21AUG97 pt was dx w/pertussis;dx was based on nasal cult, pharyngeal swab, CXR & CBC;tx w/ATB for 14 days;
Information has been received from a physician concerning a 15 year old female with an empty stomach who was vaccinated with Gardasil. Subsequently the patient fainted immediately after receiving the Gardasil. Subsequently, the patient recovered from fainting. This is one of several reports received from the same source. Additional information is not expected.
Local erythema, edema, pain, itching and HA. Benadryl 250mg PO q4-6 hours PRN, Tylenol PRN. Cool compresses to site.
strong smell, sick feeling, dark red in neck and face, heaviness in chest, back spasms, visual distortion, red marks stinging
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications and drug reactions/ allergies were unknown. On an unspecified date in June 2017, the patient was vaccinated with improperly stored doses of PROQUAD (Lot # M007960, expiration date 15-AUG-2017 or Lot # M049122, expiration date 13-JUN-2018) dose, route were unknown for prophylaxis (the nurse reported that since 02-JUN-2017 this patient and 5 more received the improperly stored doses of vaccine). The lot # and expiration date for the properly stored sterile Water diluent used to reconstitute the doses of PROQUAD was not provided. No adverse effects were reported. The temperature excursion was from 6°F to 14°F for 1 hour, no previous temperature excursion was reported, the call was because a data logger. No product quality complaint was involved. This is one of 6 cases received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA006743: US-009507513-1706USA010999: US-009507513-1706USA011000: US-009507513-1706USA011002: US-009507513-1706USA011003.
Severe chills nausea beginning late night of the vaccine (or early the next day). Next day exhausted, nauseous. Slept all day. Today, 2/16, feeling better but have some leg cramps and still feeling tired.
Information has been received from a registered nurse concerning a 13 year old male who on 10-FEB-1999 was vaccinated with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). It was reported that "now", on approximately 04-MAY-2007, the patient has a full blown case of chickenpox with more than 250 lesions. The case was reported to the health department. Unspecified medical attention was sought. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Ringing in left ear and loss of hearing.  The symptom is mostly gone after about 24 hours.
Flushed face, "feel like  my throat is closing up", dizzy  BP 149/79, PR 101 O2 sat 100%
eczematous dermatitis of face & mild dermatitis of extremities; tx DPH & Pred;
Patient was given a flu vaccine from last years formulation 2020/2021 and expired on 06/30/2021, no adverse reaction or problems noted
HR soaring to 200, 187, 166, 141 depending on the day or night, sweating, hot and cold intolerance, dizzy, extreme weight loss, swelling in legs and abdomen, heart palpitations, exercise intolerance, difficulty standing or walking, vision distortion, splotchy arms and legs, shaking, numbness in feet, fainted three times.  All of this is still going on.
c/o weird feeling in throat w/perceived difficulty getting adequate air;VS 122/86, 116;pt declined hosp eval;no dysphagia